1/31/2014 7:34:39 AM
Scientists still have a lot to learn about what’s really going wrong, in the underlying biology, of patients with Alzheimer’s Disease and Parkinson’s Disease. That’s a big reason why it’s such a minefield for little biotech startups and big pharmaceutical companies to develop drugs in those areas. But it also provides room for some creative thinkers, and Cambridge, MA-based Neurophage Pharmaceuticals says it just might have an idea that can succeed where so many have failed.
Help employers find you! Check out all the jobs and post your resume.
comments powered by